Developing a questionnaire to help doctors customise asthma management to the needs of individual patients

A study of adolescents and adults with asthma who are taking inhaled corticosteroid/long-acting beta-2-agonist inhalers (ICS/LABA), to develop a questionnaire to identify factors predicting poor asthma control

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12608000305325

Enrollment

100

Registered

2008-06-24

Start date

2008-07-29

Completion date

2009-11-25

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project will develop a simple questionnaire to allow health care professionals to identify features contributing to poor asthma control, in patients who are currently using inhaled corticosteroid/long-acting b2-agonist combination inhaler.

Interventions

Inhaled salmeterol/fluticasone. Participants will continue to use this medication at the same frequency and dose (or equivalent dose) as was previously prescribed by their own doctor. The duration of observation will be 8 weeks.

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age =14 yrs 2. Doctor diagnosis of asthma 3. Current prescription for salmeterol/fluticasone or formoterol/budesonide

Exclusion criteria

1. Recent asthma exacerbation (hospitalisation, Emergency Department visit, or steroid tablets for asthma in the previous month) 2. Other major respiratory disease e.g. COPD, or serious uncontrolled medical condition; 3. Patients who are pregnant or lactating or planning pregnancy in the next 2 months 4. Symbicort as Maintenance and Reliever Therapy

Outcome results